Lina Le
Lina Le
Lina Le is a Research Assistant in the Functional Phosphoproteomics group. She holds a Master's in Biomedical Science from the University of Melbourne, Australia.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing novel therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing novel therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society.
Lina Le is a Research Assistant in the Functional Phosphoproteomics group. She holds a Master's in Biomedical Science from the University of Melbourne, Australia.
Her master's research focused on studying long-term immune alterations in Marginal...
Her master's research focused on studying long-term immune alterations in Marginal...
Lina Le is a Research Assistant in the Functional Phosphoproteomics group. She holds a Master's in Biomedical Science from the University of Melbourne, Australia.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing novel therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing novel therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society.
Top Publications
- Davis, JE, Le, LH, Ludford-Menting, M, Holzwart, N, Handunnetti, SM, Tam, CS, Anderson, MA, Ritchie, DS, Koldej, R. Marginal Zone Lymphoma Is Associated with Dysregulated Peripheral Blood Immunity Which Is Not Changed By Ibrutinib-Venetoclax Treatment. Blood 144(Supplement 1) : 4384 -4384 2024 view publication
Career information
Share //
